Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature
/in Dendritic Cells, International Publications, Newcastle Disease Virus, Urothelial CarcinomaDendritic cells based immunotherapy
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications, Pancreatic CancerDendritic cell therapy in melanoma
/in Dendritic Cells, International Publications, Malignant MelanomaCo-delivery of tumor-derived exosomes with alpha-galactosylceramide on dendritic cell-based immunotherapy for glioblastoma
/in Dendritic Cells, Exosome, Glioblastoma, International PublicationsIncreased cycles of DC/CIK immunotherapy decreases frequency of Tregs in patients with resected NSCLC
/in Dendritic Cells, International Publications, NSCLCHematologic neoplasms: Dendritic cells vaccines in motion
/in Dendritic Cells, International PublicationsProstate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Newcastle Disease Virus, Prostate CancerDendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International PublicationsDendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience
/in Dendritic Cells, International Publications, Malignant Melanoma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer